Gyroscope Therapeutics Appoints Jessica Stitt as Chief Financial Officer

by Business Wire • 2021/03/01 • 0 Comments

LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Appoints Jessica Stitt as Chief Financial Officer.

← Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie

Ocular Therapeutix™ Announces First Patient Dosed in Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease →